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Abstract: Background: Although there are merits in using commercial “enteral nutrition formula”
(ENF) compared with blended ENF, there is a growing preference for the use of blended ENF in many
countries globally. However, the nutritional value and physical properties of blended ENF compared
with commercial ENF may be limiting its use. We have not found any evidence of a meta-analysis
on the nutritional value of blended diets in the adult population. Aim: The aim of this review was
to compare the nutritional value, physical properties, and clinical outcomes of blended ENF with
commercial ENF. Methods: The preferred reporting items for systematic reviews and meta-analyses
were used for this review. The search strategy was based on a Population, Intervention, Comparator,
Outcome framework. The following databases; Pubmed, EMBASE, PSYCInfo, and Google scholar
were searched for articles of interest using keywords, Medical Subject Heading (MeSH) and Boolean
operators (AND/OR) from the inception of each database until 23 February 2020. The articles were
evaluated for quality. Results: Based on the systematic review and meta-analysis, four distinct
themes were identified; Nutritional value, Physical properties, Clinical outcomes; and Adverse
events. The findings of this review showed inconsistencies in the macronutrient and micronutrient
values of the blenderised ENF compared with the commercial ENF. The results of the meta-analysis
demonstrated that there were no significant differences (p > 0.05) between the blenderised ENF and
the commercial ENF in relation to the fat and protein contents of the diets. However, the blenderised
ENF was significantly lower (p < 0.05) than the commercial ENF regarding the energy content of the
diets, with an overall mean difference of −29.17 Kcal/100 mL (95% CI, −51.12, −7.22) and carbohydrate
content with an overall mean difference of -5.32 g/100 mL (95% CI, −7.64, −3.00). In terms of
sodium, potassium, and vitamin A, there were no significant differences (p > 0.05) between the
blenderised and commercial ENF, although significant differences (p < 0.05) were observed between
the two diets with respect to calcium, phosphorus, magnesium, zinc, iron, and vitamin C contents.
Furthermore, the blenderised ENF showed significantly higher levels (p < 0.05) of viscosity and
osmolality than the commercial ENF. The significantly lower levels of some of the macro-nutrients
and micro-nutrients in the blenderised ENF compared with the commercial ENF and the difference in
the expected nutritional values may be due to the fact blenderised ENF is produced from common
foods. Thus, the type of foodstuffs, cooking, and processing methods may lead to loss of nutrients
and energy density. The deficits in the energy content and some of the macro- and micro-nutrients
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in the blenderised ENF compared with commercial ENF may have implications for patients’ health
and clinical outcomes. The clinical implications of the underdelivering of nutrients may include
increased risk of undernutrition, including energy malnutrition, which could have a negative effect
on body composition and anthropometric parameters, morbidity, mortality, length of hospital stay,
and costs. For outpatient care, this could increase the risk of hospital re-admission and homecare
costs. Additionally, the higher viscosity and osmolality of the blenderised ENF compared with
the commercial ENF can increase the risk of complications, including tube blockage, and impaired
delivery of feed, water, and medications, with significant implications for patients’ nutritional status
and health outcomes. Conclusion: The results of this systematic review and meta-analysis identified
significant variability in the nutritional value of blenderised ENF compared with commercial ENF.
Furthermore, the nutritional values of the blenderised ENF do not meet the expected recommended
levels compared with commercial ENF and these may have implications for patients’ nutritional
status and health outcomes, including the effect on body composition, morbidity, mortality, hospital
re-admission, and costs. Further studies are needed to elucidate the nutritional value of blenderised
ENF on patients’ clinical outcomes.
Keywords: enteral nutrition formula; blended formula; commercial feed; blenderised enteral formula;
blenderised tube feeding; enteral tube feeding; nutritional value; physical properties of food
1. Introduction
Patients who are treated in hospital, long term facilities, or receive care at home, including those
who are critically ill, are at risk of malnutrition [1,2]. The effect of malnutrition can be profound,
with a higher rate of complications, such as increased length of hospital stay, and a higher risk of
morbidity and mortality [2]. The provision of enteral nutrition is a useful way of mitigating these
complications [1,3]. Enteral feed includes either a pre-packaged, ready-to-use formula or a powder
formula which requires reconstitution, which can be delivered through enteral feeding tubes.
Enteral tube feeding is an effective method of providing nutritional support to individuals with a
functional gastrointestinal tract who may be unable to meet their nutritional requirements through the
oral route [2,4,5]. Individuals may be unable to meet their nutrition needs due to various diseases
such as stroke, motor neurone disease, multiple sclerosis, dementia, head and neck cancer, and other
conditions which could impair their swallowing ability [4]. Therefore, enteral tube feeding can be used
for the management of malnutrition or can be a prophylactic measure to reduce the risk of malnutrition.
Due to the varied nature of the conditions that impact on nutritional intake and the requirements
of individual patients, a range of nutritional formulas have been developed [3]. Although the history
of enteral nutrition formula (ENF) can be traced to the use of homemade and/or blended ENF, the use
of commercial ENF has been on the increase globally [3,6], especially in developed countries due partly
to advances in technology and the increasing ageing population [7]. For example, patients receiving
home enteral nutrition increased from 34,000 in 1989 to 344,000 in 2014 in the USA [6]. In the UK,
the prevalence of home enteral tube feeding fluctuated between 2010 (n = 3430) and 2015 (n = 6270),
with an overall increase of 10% since 2010 [8].
The main commercial ENF include standard polymeric, oligomeric, and monomeric diets
(elemental formulas) and disease-specific formulas [3,6,9,10]. Despite the merits of using commercial
ENF, including prevention of weight loss and reduced microbial risks compared with blended
ENF [2,10–13], there is a growing preference to the use of blended ENF [3,14]. In some developing
economies such as Iran, the use of blended ENF appears to be the primary enteral feed of choice and
most hospitals are still using the traditional hospital prepared blended ENF [1,3]. The blended ENF is
any food, whether liquid or food mixture, that is administered through an enteral feeding tube that is
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not water, medicine, and/or commercial ENF [6]. According to Brown [10], it is a homemade food that
is blended to a smooth consistency.
The use of blended ENF may be due to the fact it is more affordable and improves reflux and
bowel problems [12]. It has also been suggested that blended ENF are more natural, promote flexibility
in the selection of ingredients, and enable patients to consume the same food as members of their
family [6]. However, the use of blended ENF is limited by concerns relating to its nutritional value
and physical and chemical instability compared with commercial ENF [2,6,12]. The main problems
with blended ENF include the value of the nutrients, the viscosity of the formulas, and whether these
formulas can indeed provide the daily nutritional requirements for the patients [2,6,12]. Therefore,
the nutritional value of enteral nutrition formulas in the current review was based on the caloric density
and the percentage of macronutrients and micronutrients to meet the UK and international dietary
recommendations, although the nutritional quality of the enteral formula is also important [15,16].
The physical properties of blendrised ENF may be associated with adverse events such as tube blockage,
diarrhoea, and constipation [6]. These limitations have implications for patients’ nutritional status and
health outcomes and may explain why the British Dietetic Association currently does not recommend
the use of a blended diet as a first choice in enteral tube feeding [10].
Therefore, it is necessary to evaluate the evidence concerning the use of blended ENF compared
with commercial ENF as the strengths and limitations of these formulas are not consistent. While
previous reviews have tended to focus on a critical review of this topic [3], integrative review [17],
and reviews involving children [18], there appears to be no evidence drawn from a meta-analysis
on the nutritional value of blended diets in the adult population. The present review is a systematic
review and meta-analysis that aims to compare the nutritional value, physical properties, and clinical
outcomes of blended ENF with commercial ENF.
2. Methods
The preferred reporting items for systematic reviews and meta-analyses (PRISMA) [19] was the
method used for this review.
2.1. Study Designs and Samples
Experimental designs, including case-control, cross-sectional, and cohort studies, were included
in this review and the samples were blended diets or blenderised ENF and commercial ENF.
2.2. Type of Population
Any person over the age of 18, with any type of disease that required enteral feeding.
2.3. Type of Intervention and Comparison
Blended versus commercial ENF.
2.4. Types of Outcome
The outcome measures of interest include;
• Nutritional value of enteral nutrition formulas—Energy, Macronutrients (protein, carbohydrate,
fat), Micronutrients (sodium, potassium, calcium, phosphorus, magnesium, zinc, iron, vitamin A,
vitamin C)
• Physical properties—Viscosity, osmolality
• Any type of clinical outcomes
• Adverse events—diarrhoea, tube blockage
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2.5. Inclusion and Exclusion Criteria
The inclusion and exclusion criteria used to select studies for this review were based on the
Population, Intervention, Comparator, Outcomes (PICO) framework [20].
Inclusion Criteria: Studies involving the population or problem of interest that included
patients (adults) on blenderised ENF or blended tube feeding (BTF) were selected for this review.
The intervention criteria were blended or blenderised ENF, while the comparator was the commercial
ENF. The outcomes of interest for selecting studies were nutritional value, physical property, clinical
outcomes, and adverse events. The studies included in this review were quantitative studies with a
comparison group.
Exclusion Criteria: Studies involving children aged below 18 years and individuals on normal
oral dietary intake were excluded from the review. Furthermore, patients on parenteral nutrition,
parenteral plus enteral nutrition, and studies involving qualitative outcomes, such as patients’ feelings,
were excluded from the review.
2.6. Search Strategy
The following databases; Pubmed, EMBASE, PSYCInfo, and Google scholar were searched
for articles of interest using keywords, Medical Subject Heading (MeSH) and Boolean operators
(AND/OR). The searches were carried out from the inception of each database until 23rd February
2020 and included the following keywords and combinations; Patients on blended tube feeding OR
blended tube feeding AND blended tube feeding OR blenderised tube feeding OR blenderised enteral
formula OR Homemade blenderised food OR blenderised diet OR blenderised feed OR blended
formula. The search strategy was based on the Population or Problem, Intervention, Comparator,
Outcomes—PICO framework [20].
The studies reviewed were screened and evaluated for eligibility for inclusion based on the
PRISMA guidelines [19] (Figure 1). This search and selection process of articles was conducted by two
researchers (OO, OOO) and the resolution of differences was by consensus.
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Figure 1. Preferred reporting items for systematic reviews and meta-analyses (PRISMA) flow chart on
selection and inclusion of studies.
2.7. Data Extraction
The articles retrieved from the databases were exported to ENDNote (Analytics, Philadelphia,
PA, USA) and duplicates were removed. The data from the included studies were extracted by one
researcher (OO) and cross-checked by the other four researchers (OOO, AARA, X-HW, JB).
2.8. Statistical Analysis
The data extracted from the studies included in the review were analysed using RevMan
(Review Manager, 5.3) [21]. The data analysis involved meta-analysis and sensitivity analysis.
The sensitivity analysis was conducted by removing one study at a time (including studies with
multiple sites and different blenderised ENF) from the meta-analysis to test for consistency of the effect
of blended ENF on the parameters of interest. It was to check whether one particular study was having
a profound effect on the results of the meta-analysis and how robust the differences were between
the intervention and the control. Due to the varied nature of the studies included, the random-effects
model was used for the meta-analysis and heterogeneity was measured by the statistic I2. A p-value of
0.10 was used to establish the statistical significance of heterogeneity.
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2.9. Effect Size
The overall effect of the intervention in terms of statistical significance was determined by a
p-value of <0.05 and the results of the meta-analysis were presented in the form of a forest plot.
3. Results
3.1. Managing the Data for Meta-Analysis
With respect to the Mokhalalati et el. [22] study, data from BTF samples (three samples over
three days) from three different sites (hospitals) for the standard formula were combined, while
data from three different sites (hospitals) for the therapeutic formulas were also combined and
compared separately with samples of commercial ENF (sample size halved for each set of analysis)
as recommended by Higgins and Green [23]. Therefore, for continuous outcomes in case of multiple
arms, only the sample size was divided up and the means and standard deviations left unchanged.
Data from commercial powder formulas (ensure powder and tap water in Hospitals A and B) were
compared to blended ENF developed in Hospitals A and B, respectively, in the Sullivan et al. [24]
study. On the other hand, the results of the commercial ENF (liquid and powder) were combined and
compared with the homemade BTF in the Vieira et al. [25] study. The median and interquartile range
(IQR) were converted to mean and standard deviation using a formulae proposed by Wan et al. [26].
Twelve studies were included in the systematic review including four studies included in the
meta-analysis. Two studies each were conducted in Brazil [2,25], Iran [1,27], and the USA [6,28] and
one study was conducted in each of the following countries (Table 1); Philippines [24], Poland [29],
UK [12], Saudi Arabia [22], Thailand [30], and Greece [31]
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Table 1. Shows results of the data extracted from the studies included.
Citation Country Aim/Objective ofStudy Study Design
Study Method/Sample
Size/Description Age (Years) STUDY Results/Conclusion
Jazayeri et al. [1] Iran
To evaluate the effects
of standard enteral
feeding compared
with
hospital-prepared
blended formula
among Intensive Care
Unit (ICU) patients.
Case-control study
A total of 80 patients were involved
in the study. These included 40
patients in a standard enteral feeding
group and another 40 patients in the
hospital-prepared blended
formula group.
Hospital-prepared
blended formulas:
50.1 ± 18.7 Years
Standard enteral feeding:
49.9 ± 18.1 Years
There was increased macronutrient
intake in the standard ENF group
and this helped in patients’ recovery.
The standard enteral ENF has more
benefits than hospital-prepared
blended ENF for ICU patients.
Borghi et al. [2] Brazil
To evaluate the
nutritional quality
and cost of
blenderised tube
diets (BTD).
In-vitro experimental
study
Only five BTD out of 14 collected
BDT recipes were analysed for their
nutritional properties while the
commercial foods were based on
portion size and manufacturer’s
information
Not Applicable
Blenderised tube feeding diets were
highly variable and with
inconsistent nutritional value.
Hurt et al. [6] USA
To determine the
prevalence and use of
BTF and frequency of
use in adults
receiving HEN.
Cross-sectional study
All patients who had follow-up
appointments at the HEN clinic
were approached during their
appointment to participate
in completing the survey
electronically or fill in a paper
questionnaire. The survey consisted
of 15 questions.
60.5 Years
Most of the adult HEN patients use
BTF as part of their nutrition
regimen during tube feeding.
Patients did not report any
significant concerns with BTF.
Madden et al. [12] UK
To examine the risks
of blended formula
providing
nutritionally
adequate intake.
In-vitro
experimental study
A blended formula was made using
three different methods (professional,
jug, and stick blenders) and three
storage procedures. The feed
samples were delivered through 10-,
12-, and 14-French (Fr) enteral
feeding tubes and both blockages
and the time taken were recorded.
Not Applicable
There was no risk of tube blockages
when one blended ENF recipe made
using three methods was delivered
via a 14-Fr tube. After removing the
waste (residues remaining on
utensils and unsieved fraction),
the remaining feed provided less
than 95% of the estimated
requirements for energy, fibre, iron,
zinc, selenium, and vitamins A, D, E,
and B6
Nutrients 2020, 12, 1840 8 of 21
Table 1. Cont.
Citation Country Aim/Objective ofStudy Study Design
Study Method/Sample
Size/Description Age (Years) STUDY Results/Conclusion
Mokhalalati et al.
[22] Saudi Arabia
To compare the
microbial safety,
nutritional content,
and physical
properties of BTF and
commercially
prepared formulas
(CPF).
In-vitro
experimental study
18 samples of BTF were collected
from 3 hospitals. Samples of a CPF
were also collected for comparison.
There is a high degree of variability
in nutrient content and physical
properties of BTF. Cholesterol,
sodium, vitamin A, and vitamin B6
levels for all BTF were higher than
the commercial ENF. However,
the values for unsaturated fat,
nonferrous extract (NFE), calories,
calcium, phosphorus, magnesium,
zinc, iron, copper, and vitamins D, E,
B3, and C were lower for all BTF
compared with commercial ENF.
Sullivan et al. [24] Philippines
To evaluate the
nutritional content
and viscosity of
hospital-prepared BTF.
In-vitro
experimental study
Two different BTFs (one standard
and one modified) were collected
from each hospital on three separate
occasions and analysed for
macronutrients, micronutrients,
and viscosity.
Not Applicable
Hospital prepared BTF showed
unpredictable levels of
micronutrients and macronutrients
and may provide less than the
required amounts of nutrients.
In addition, the viscosity of these
formulas may not be suitable for
infusion through feeding tubes.
Vieira et al. [25] Brazil
To evaluate the
nutritional and
microbiological
quality of commercial
enteral and
homemade
blenderised
whole foods.
Cross-sectional study
66 samples of commercial (n = 33)
and noncommercial (n = 33) enteral
diets were collected at the homes of
patients on HEN
73 Years (20–100 Years)
The homemade blenderised ENF
demonstrated low values of energy
and macronutrients and provided
less than 50% of the
recommended values.
Jolfaie et al. [27] Iran
To compare the
nutritional quality of
commercial enteral
nutrition and
blenderised
enteral formula
Cross-sectional study
150 patients were fed blended
formula and 120 patients were fed
commercial ENF
Blenderised formula:
55.46 ± 20.19 Years
Commercial Formula:
53.13 ± 20.35 Years
Commercial ENF contained more
energy and nutrients compared with
blended ENF and they are more
effective in meeting the nutritional
requirements of patients who are
fed enterally.
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Table 1. Cont.
Citation Country Aim/Objective ofStudy Study Design
Study Method/Sample
Size/Description Age (Years) STUDY Results/Conclusion
Johnson et al. [28] USA
To compare microbial
loads of a standard
polymeric commercial
formula (CF), a BTF
made using baby
food (BTF-BF), and a
BTF prepared from
blending whole food
(BTF-WF).
In-vitro
experimental study
Three tube-feeding formulas (CF,
BTF-BF, BTF-WF) were compared. Not Applicable
The results show that BTF recipe
selection and adherence to safe food
handling provide a safe feeding that
is comparable to CF in the
hospital setting.
Klek et al. [29] Poland
To examine the effect
of commercial enteral
nutrition (specialised
home enteral
nutrition) programme
on clinical outcomes.
Cohort
All patients who had received home
enteral tube feeding (HETF) with
homemade blenderised diets for 12
months before starting a specialized
nutrition programme for another 12
months consisting of the provision of
commercial enteral nutrition
formulas and guidance on
nutrition support.
52.5 Years
It was demonstrated that the
specialized HETF care programme
consisting of commercial ENF and
nutrition support team reduces
morbidity and costs related to
long-term enteral feeding at home.
Tiyapanjanit &
Boonyavarakul [30] Thailand
To compare blood
glucose parameters
and cost between the
Phramongkutklao’s
diabetic formula and
commercial diabetic
formula in patients
with type 2 diabetes.
Cross-over study
Participants were fed using 24 h
continuous feeding for three days.
The Phramongkutklao’s diabetic
formula was followed by
commercial diabetic formula
continuously for 36 h each.
79.80 ± 11.03 Years
The Phramongkutklao’s diabetic
formula had significantly lower
mean plasma glucose and was less
expensive than the commercial
diabetic formula.
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Table 1. Cont.
Citation Country Aim/Objective ofStudy Study Design
Study Method/Sample
Size/Description Age (Years) STUDY Results/Conclusion
Papakostas et al.
[31] Greece
To evaluate the body
composition
characteristics and
nutritional status in
HNC patients who
are receiving either
the prescribed
commercial enteral
nutrition formula or
decided on
home-made BTF
Quasi-experimental
design
All patients were prescribed to
receive, on an out-patient basis, a
commercially available enteral
nutrition formula. Patients with low
income and no public health
insurance were recommended to
have equivalent home-made enteral
formula.
Both groups were also advised to
consume, yogurt with honey,
ice-cream, and fruit and vegetables.
212 patients including 112 who
received the commercial formula, 69
who switched to BTF, and 31 that
were prescribed to receive a
home-made formula of standard
ingredients were involved in
the study.
Commercial:
56.4 ± 3.6 Years
Home-made:
55.9 ± 3.5 Years
Blenderised Family Food:
56.2 ± 3.8 Years
The results show that home-made
and blenderised foods do not
adequately support the nutritional
requirements of patients with HNC.
Abbreviations: Blenderised tube diets (BTD); Blenderised tube feeding (BTF); Enteral Nutrition Formulas (ENF); Home enteral nutrition (HEN); Home enteral tube feeding (HETF); Head &
Neck cancer (HNC).
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3.2. Assessment of Risk of Bias and Evaluation of Quality
An appraisal of the quality of the articles was carried out using a critical appraisal skills programme
(CASP) tool [32] and the Joanna Briggs Institute Critical Analysis Tool for Cross-sectional Studies [33]
(Appendix A, Tables A1 and A2). One researcher (JB) carried out the quality evaluation of the studies
included and this was cross-checked by the other researchers. The data available in the studies were
the only information used to assess the quality. Only studies involving human subjects where quality
evaluation tools were available were assessed.
Based on the systematic review and meta-analysis, four distinct themes were identified; Nutritional
value, Physical properties, Clinical outcomes, and Adverse events.
3.3. Nutritional Value of Blenderised Enteral Nutrtion Formulas
In the studies conducted by Borghi et al. [2] and Mokhalalati et al. [22], the nutritional
value of blenderised ENF were found to be highly variable and inconsistent (Table 1). Similarly,
Sullivan et al. [24] hospital prepared BTF also demonstrated unpredictable levels of micronutrients
and macronutrients and suggested that these diets may provide less than the required amounts of
nutrients. In the Vieira et al. [25] study, energy and macronutrient values in the blenderised ENF were
lower and provided less than 50% of the recommended values.
Jolfaie et al. [27] noted that commercial ENF contained more energy and nutrients compared with
blended ENF.
The results of the meta-analysis demonstrated that there were no significant differences (p > 0.05)
between the blenderised ENF and the commercial ENF in relation to the fat and protein contents of the
diets (Table 2). However, the sensitivity analysis showed significant differences (p < 0.05) between
these diets with respect to fat content when Sullivan et al. [24] blenderised ENF B was removed and for
protein when Mokhalalati et al. [22] standard and therapeutic formulas were removed one at a time
from the meta-analysis.
Table 2. Shows the results of the meta-analysis of macro- and micro-nutrients in blenderised and
commercial ENF.
Outcomes Number ofStudies/Experiments
Number of
Samples
Mean Difference
(95% CI) p-Value I
2 %
Fat (g/100 mL) 6 107 −0.63 [−1.41, 0.14] 0.11 74
Protein (g/100 mL) 6 107 −0.76 [−1.64, 0.12] 0.09 76
Sodium (mg/100 mL) 5 41 −29.22 [−65.90, 7.46] 0.12 81
Potassium (mg/100 mL) 5 41 −27.68 [−74.88, 19.53] 0.25 88
Vitamin A (mcg/100 mL) 4 34 −2.03 [−37.73, 33.68] 0.91 82
However, the blenderised ENF was significantly lower (p = 0.009) than the commercial ENF
with respect to the energy content of the diets with an overall mean difference of −29.17 Kcal/100 mL
(95% CI, −51.12, −7.22) (Figure 2). Similarly, the carbohydrate content of the blenderised enteral
formula was significantly lower (p < 0.001) than the commercial ENF, with an overall mean difference
of −5.32 g/100 mL (95% CI, −7.64, −3.00) (Figure 3). The results of the sensitivity analysis also
demonstrated significant differences (p < 0.05) between the blenderised ENF and the commercial ENF
with respect to the energy density and carbohydrate content of the diets.
Nutrients 2020, 12, 1840 12 of 21
Nutrients 2020, 12, x FOR PEER REVIEW 12 of 22 
 
 
Figure 2. Shows energy content of blenderised and commercial ENF (Kcal/100 mL). 
 
Figure 3. Shows carbohydrate content of blenderised and commercial ENF (g/100 mL). 
In terms of sodium, potassium, and vitamin A, the results of the meta-analysis showed that the 
levels of these micronutrients were not significantly different (p > 0.05) between the blenderised and 
commercial ENF (Table 2). However, significant differences (p < 0.05) were observed between the two 
diets with respect to calcium, phosphorus, magnesium, zinc, iron, and vitamin C contents (Figures 
4–9, respectively). The overall mean differences showed that the blenderised ENF was significantly 
lower (p < 0.05) by −24.64 mg/100 mL (95% CI, −41.29, −7.99) with respect to calcium levels, −25.21 
mg/100 mL (95% CI, −40.70, −9.72) for phosphorus, −11.28 mg/100 mL (95% CI, −17.07, −5.48) for 
magnesium, −0.92 mg/100 mL (95% CI, −1.37, −0.48) for zinc, −0.74 mg/100 mL (95% CI, −1.05, −0.42) 
for iron, and −10.86 mg/100 mL (95% CI, −12.78, −8.94) for vitamin C. Based on the sensitivity test, the 
results between the blenderised ENF and commercial ENF were also significantly different (p < 0.05) 
regarding calcium, phosphorus, magnesium, zinc, iron, and vitamin C contents. 
 
Figure 4. Shows calcium content of blenderised and commercial ENF (mg/100 mL). 
 
Figure 5. Shows phosphorus content of blenderised and commercial ENF (mg/100 mL). 
Figure 2. tent of blenderised and co mercial ENF (Kcal/100 mL).
Figure 3. S s c r r te content of blenderised and co mercial ENF (g/100 mL).
In terms of so i , potassium, and vitamin A, the results of the meta-analysis showed that
th l vels of these micronutrients were not significantly different (p > 0.05) between th bl nderised
and commercial ENF (Table 2). However, significant differences (p < 0.05) were observed between
the two diets with respe t to calcium, phosphorus, agnesium, zinc, iron, and vitamin C contents
(Figures 4–9, r spectively). The overall mean differences s ow d that the blenderised ENF was
significantly lower (p < 0.05) by −24.64 mg/100 mL (95% CI, −41.29, −7.99) with respect to calcium
levels, −25.21 mg/100 mL (95% CI, −40.70, −9.72) for phosphorus, −11.28 mg/100 mL (95% CI, −17.07,
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sensitivity test, the results between the blenderised ENF and commercial ENF were also significantly
different (p < 0.05) regarding calcium, phosphorus, magnesium, zinc, iron, and vitamin C contents.
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3.5. Clinical Outcomes
According to Hurt et al. [6], most of the adult home enteral nutrition patients use BTF as part of
their nutrition regimen during tube feeding and these patients did not report any significant concerns
with BTF. Furthermore, Tiyapanjanit and Boonyavarakul [30] reported that the diabetic formula had
significantly lower (p = 0.022) ean plas a glucose (122 ± 26.25 mg/dL) than the commercial diabetic
formula (14 .68 ± 36.9 / ) s also less expensive. In the hospital setting, Johnson et al. [28]
revealed that BTF recipe selection and adhere c t i r ided a safe f eding that is
comparable to c mmercial formula.
However, evidenc f y by Jazayeri et al. [1] showed that there was incr ased
macronutrient intake i t ercial ENF group and this was effective in pr moting patients’
recovery compared with blenderised E F. The authors concluded that the co mercial ENF has more
benefits than blenderised E F in patients in intensive care unit. Klek et al. [29] also showed that the
specialised home enteral tube feeding (HETF) care programme consisting of commercial ENF and a
nutrition support team reduced morbidity and costs related to long-term enteral feeding at home.
While Papakostas et al. [31] found that blenderised foods do not adequately support the nutritional
requirements of patients with head and neck cancer, Jolfaie et al. [27] observed that commercial ENF
are more effective in meeting the nutritional requirements of patients who are fed enterally compared
to blenderised ENF.
3.6. Adverse Events
According to Hurt et al. [6], about 12.5% of patients studied had concerns about the safety of
blenderised ENF. However, 83.3% of the patients who used blenderised ENF did not experience nausea,
vomiting, fever, or diarrhoea. In terms of tube blockages and time, while no blockages occurred in the
standard commercial ENF irrespective of any tube diameter, two blockages occurred in the blendrised
ENF A while using the 10Fr and 12 Fr tubes in the study by Madden et al. [12]. In addition, it was also
significantly quicker to deliver the standard commercial ENF through the three tubes compared with
the blended ENF [12].
4. Discussion
The findings of this review revealed inconsistencies in the acro- utrient and micro-nutrient
values of the bl i compared with t commercial formula. In addition, the nutritional
value of the blenderised ENF did not meet all the expected nutrient standards compared with the
commercial die .
The results of th m ta-analysis demonstrate that although there were no ignificant differences
(p > 0.05) between blenderise ENF and commercial ENF in terms of fat, rotein, sodium, potassium,
and vitamin A contents, the differences were significant (p < 0.05) with respect to the energy density
and other nutrients measured; carbohydrate, calcium, phosphorus, magnesium, zinc, iron, and vitamin
C. Significantly higher (p < 0.05) levels of these nutrients were found in the commercial formula
compared with the blenderised ENF. Furthermore, the results demonstrated that blenderised ENF had
significantly higher (p < 0.05) levels of viscosity and osmolality than the commercial ENF and that the
blenderised ENF also presented with a significant level of variability in their physical properties.
In relation to the clinical outcomes, the results of this review suggest that some of the patients
may not be reporting significant concerns with the blenderised ENF [6]. According to Martin et al. [34],
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food based blendrised ENF provides a sense of normalcy for patients and caregivers of using regular
foods. Furthermore, blenderised ENF can create a sense of enjoyment of meals, control of the foods
that are used, and can boost the fibre content, phytonutrients, and pre-biotics in the diet [34]. However,
challenges remain concerning deficits in the nutritional value, which may have implications for clinical
outcomes. In addition, the delivery of blenderised ENF through feeding tubes may present significant
challenges due to the high viscosity, osmolality, and increased risk of tube blockage in patients on
enteral tube feeding.
The reduced macro-nutrient and micro-nutrient levels and energy density of blenderised ENF
compared with commercial ENF is consistent with the Borghi et al. [2] study, which revealed energy
density in blenderised ENF could range from 0.60–1.08 Kcal/mL, which represents low to normal energy
density based on the European Society for clinical nutrition and metabolism (ESPEN) guidelines [35].
According to Lochs et al. [35], normal energy formulas should provide 0.9–1.2 Kcal/mL of energy.
Energy levels in enteral feeds above this range are considered high, whereas energy density below the
range is seen as low [35].
For standard enteral feed, which is suitable for most patients, the energy density should be
1 Kcal/mL with or without fibre [36]. On the other hand, high energy feed, which is usually used for
patients on fluid restriction or increased nutritional requirements, should contain 1.2–2.0 Kcal/mL,
while low energy formulas for patients with low energy requirements should have 0.5–1 Kcal/mL [36].
Mokhalalati et al. [22] found that the levels of vitamin A, sodium, and cholesterol in the
blenderised ENF were significantly higher than the commercial ENF, although the levels of unsaturated
fat, carbohydrate, energy, calcium, phosphorus, magnesium, zinc, iron, copper, and vitamin C were
significantly lower for all the blenderised ENF compared with commercial ENF. Mokhalalati et al. [22]
also observed that the blenderised ENF did not provide the predicted nutrient levels compared with
the commercial ENF which demonstrated a high degree of accuracy in providing the expected nutrients
with limited variability in nutritional values and physical properties.
The nutritional value of blenderised ENF prepared from usual foodstuffs is often determined by
the nutritional value of the foods used and these can be influenced by a range of factors including the
geographical source of the food and the variety of the food [24]. Therefore, the significantly lower
levels of some of the macro-nutrients and micro-nutrients in the blenderised ENF compared with
the commercial ENF and the difference in the expected nutritional values may be due to the fact that
blenderised ENF is produced from common foods such as milk, egg, meat, fruits, and vegetables which
are cooked and pureed in a blender or mixer, often requiring sieving to remove large food particles [25].
Other factors that may lead to loss of nutrients could include the cooking method, processing method,
the type of foodstuffs, stage of maturity of the crop used for food preparation, harvesting and storage
methods, and human factors such as errors in measurements [22]. Another reason for the differences
between the blenderised ENF and the commercial ENF is that there are no standard formulations
for blenderised ENF preparations and the foodstuffs vary from setting to setting [27]. These factors
may lead to the loss of a considerable amount of nutrients and energy in the feed [25]. The study
by Madden et al. [12] also showed that after removing the waste (residues remaining on utensils and
unsieved fraction), the remaining feed provided less than 95% of the estimated requirements for energy,
fibre, iron, zinc, selenium, and vitamins A, D, E, and B6.
There is evidence that an institutionally prepared high-calorie formula did not provide the
expected 1.5 Kcal/mL of energy; instead, it provided 1.0 Kcal and the formula did not meet the USA
Recommended Dietary Allowance (RDA) for some of the minerals and vitamins [24]. In contrast,
commercial ENF expected to provide 1.0 Kcal/mL and 1.5 Kcal/mL met all the nutrient and energy
requirements [24]. It is essential that enteral formulas are well balanced in terms of their nutritional
value, which is the basis for good health [37]. This is because the nutritional needs of patients are
varied and often depend on their current and past nutritional status and the state of the complexity of
their condition [38].
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The implications of the nutritional differences between the blenderised ENF and the commercial
ENF has public health significance because the patients who are fed the blenderised ENF may become
deficient in energy, carbohydrate, and some of the micro-nutrients, including calcium, phosphorus,
magnesium, zinc, iron, and vitamin C, as they do not meet the RDA for these nutrients compared
with commercial ENF [2,24,25]. The adult RDA is seen as the average daily level of nutritional intake
that is enough to meet the nutrient requirements of nearly all healthy people [39]. This standard
is similar to the UK Public Health England [16] recommendations for energy, macro-nutrients, and
micro-nutrients for different age groups including 19–64 years in the general population. In this regard,
the daily energy intake recommended for males in this age group is 2500 Kcal/day and 2000 Kcal/day
for women [16]. For carbohydrates, the recommended allowance is at least 333 g/day for males and
267 g/day for females in this age group [16]. While standard commercial ENF contain macro-nutrients
and micro-nutrients that meet the standards recommended for healthy persons, it has also been shown
that based on the caloric intake of a normal diet, the micro-nutrients supplied in commercial ENF
are often above the Dietary Reference Values for healthy populations [3,37]. However, more energy
and nutrients may be required in patients who are critically ill [3]. The calculation of the caloric
requirements for patients is often based on equations such as the Harris-Benedict equation and indirect
calorimetry for hospitalised patients, although the usual range is 25–30 Kcal/kg/day [38,40].
In order to provide the Recommended Dietary Intake for vitamins and minerals and reduce
the risk of nutrient deficiency, the patient has to be fed 1200 to 1500 Kcal/day [15]. Iacone et al. [37]
examined the micro-nutrient contents of 62 enteral nutrition formulas manufactured by five different
companies at the doses of 1500 and 2000 Kcal/day and found that the daily requirements for all the
micro-nutrients were covered, except for vitamin K and fluoride. The results of the present review
are in agreement with these findings with respect to the micro-nutrient value of the commercial ENF.
It is also clear that adequate macro-nutrients and micro-nutrients are necessary for the prevention and
management of nutritional deficiency and the sustenance of normal metabolism [38].
The clinical implications of the underdelivering of nutrients may include adverse clinical outcomes
such as accelerated loss of lean body mass [24]. In the study by Sullivan et al. [24], the mean calcium
content obtained from 1000 Kcal for one of the blenderised ENF was 90 mg, while the US Dietary
Recommended Reference Intake is 1000 mg calcium per day for adults in the 19–50 year group, and
this is higher for patients who are at risk of osteoporosis.
The inadequacy in the energy and some of the nutrients in the blenderised ENF reduces the
effectiveness of the nutritional therapy, which may increase the risk of undernutrition, including energy
malnutrition, morbidity, mortality, length of hospital stay, and costs [2]. For outpatient care, this could
increase the risk of hospital re-admission and homecare costs [2].
In a study by Vieira et al. [25], the patients that received blenderised ENF obtained less than 50%
of the recommended values of nutrients and this had a significant impact on anthropometric and
body composition parameters compared with those on commercial ENF. Furthermore, the study by
Papakostas et al. [31] found that patients who consumed blenderised ENF during chemo-radiation
therapy had a significant reduction in body mass index compared with those who had commercial
ENF. In contrast, commercial ENF has been shown to improve patients’ weight and decrease infectious
complications and hospital admissions [41].
The variations in the chemical composition, molecular sizes, solubility, and value of the
macronutrients in ENF may influence the osmolarity, absorption, utilization of nutrients, and patients’
clinical outcomes [15]. Mokhalalati et al. [22] noted that the mean viscosity for the blenderised ENF
was 2276.9 Centipoise (cP), compared with 10.84 cP for the commercial ENF, and for the commercial
ENF that are fed unaided through small diameter enteral feeding tubes, such as 8Fr, the viscosity is
usually less than 60 cP. This was a 200-fold higher level of viscosity and a two-fold higher level of
osmolality in the blenderised ENF compared with commercial ENF [22]. The higher viscosity in the
blenderised ENF could suggest that it will be difficult for some of the samples to flow easily through
nasogastric and other enteral feeding tubes with a small diameter [24].
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Therefore, the higher viscosity and osmolality of the blenderised ENF compared with the
commercial ENF can increase the risk of complications including tube blockage and impaired delivery
of feed, water, and medications, with significant implications for patients’ nutritional status and
health outcomes.
Limitations
The number of studies included in the meta-analysis was only four and this may affect its wider
application. Due to the limited number of studies investigating clinical outcomes and the varied
nature of the parameters measured by the studies, the data were insufficient to run a meta-analysis
and present the forest plot for clinical outcomes. In addition, the lack of a quality evaluation tool to
assess the in-vitro experimental studies and the conversion of the median and interquartile range to
mean and standard deviation are potential limitations in this review.
5. Conclusions
The results of this systematic review and meta-analysis identified significant variability in the
nutritional value of blenderised ENF compared with commercial ENF. Additionally, the nutritional
values of the blenderised ENF do not meet the expected recommended levels compared with commercial
ENF and these may have implications for patients’ nutritional status and health outcomes, including
the effect on body composition, morbidity, mortality, hospital re-admission, and costs. Further studies
are needed to elucidate the nutritional value of blenderised ENF on patients’ clinical outcomes.
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Appendix A
Table A1. CASP Critical Analysis Tool for cohort studies.
Klek et al. [29] Jazayeri et al. [1] Tiyapanjanit et al.[30]
Papakostas et al.
[31]
Section A
1. Did the study address a
clearly focused issue? YES YES YES YES
2. Was the cohort recruited in
an acceptable way? YES YES YES YES
3. Was the exposure accurately
measured to minimise bias? YES YES YES YES
4. Was the outcome accurately
measured to minimise bias? YES YES YES YES
5a. Have the authors
identified all important
confounding factors?
YES YES YES YES
5b. Have they taken account
of the confounding factors in
the design and analysis?
YES YES YES YES
6a. Was the follow up of
subjects complete enough? YES YES YES YES
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Table A1. Cont.
Klek et al. [29] Jazayeri et al. [1] Tiyapanjanit et al.[30]
Papakostas et al.
[31]
6b. Was the follow up of
subjects long enough? YES YES
Unclear why the
first and third day
of enteral feeding
were monitored
YES
Section B
7. What are the results of
the study?
SpecializedHETF
care program
reduces morbidity
and costs related to
long-term enteral
feeding at home.
Albumin levels
were significantly
increased in the
manufactured
standard enteral
formula compared
to the hospital
prepared blended
formula.
Hospital
blenderised
formula resulted in
significantly lower
mean plasma
glucose, cost, and
number of capillary
blood glucose tests,
compared to
commercial
diabetic formula.
Commercially
available, oncology
specific enteral
feeding formulas
have significantly
better nutritional
profiles than the
blenderised
home-cooked diets.
8. How precise are the results?
The results were
significant and
presented the CIs,
demonstrating
reasonable
precision
Significant results
were presented
Significant results
were presented
Significant results
were presented
9. Do you believe the results? YES YES YES YES
Section C
10. Can the results be applied
to the local population? YES YES
NO—sample of 10
participants YES
11. Do the results of this
study fit with other
available evidence?
YES Unclear NO Unclear
12. What are the implications
of this study?
Patients receiving
home enteral
nutrition should be
adequately
supervised and
provided with
appropriate enteral
diets to maximise
the benefits of such
a therapy.
Standard enteral
formula has more
benefits than
hospital-prepared
blended formulas
for ICU patients.
The hospital
diabetic formula
had significantly
lower mean plasma
glucose and was
less expensive than
the commercial
diabetic formula.
Home-made and
family-cooked food
is inappropriate
and may actually
be harmful for
malnourished
HNC patients
scheduled to
receive concurrent
treatment.
Abbreviations: CASP (critical appraisal skills programme); ICU (Intensive Care Unit); Homet enteral tube feeding
(HETF); Confidence Intervals (CIs).
Table A2. Joanna Briggs Institute Critical Analysis Tool for Cross-sectional Studies.
Hurt et al. [6] Vieira et al. [25] Jolfaie et al. [27]
1. Were the criteria for inclusion
in the sample clearly defined? YES YES YES
2. Were the study subjects and
the setting described in detail? YES
YES—commercial and
non-commercial
enteral feeds
YES—both participants and
commercial and
non-commercial formulas
3. Was the exposure measured
in a valid and reliable way? YES NOT APPLICALBE YES
4. Were objective, standard
criteria used for measurement of
the condition?
YES—received
commercial enteral
nutrition for 3 weeks
YES—for each
commercial and
non-commercial
enteral feeds
YES—for commercial and
non-commercial formulas
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Table A2. Cont.
Hurt et al. [6] Vieira et al. [25] Jolfaie et al. [27]
5. Were confounding
factors identified? YES NO YES
6. Were strategies to deal with
confounding factors stated? NOT APPLICABLE NO YES
7. Were the outcomes measured
in a valid and reliable way?
YES—developed and
validated a survey, but
analysis not provided
YES—the content of
the feeds
YES—the content of
the feeds
8. Was appropriate statistical
analysis used? YES YES YES
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